InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,522.40
(
0.59%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.64
(
-0.07%
)
Bitcoin
65,650.17
(
1.05%
)

Replies to post #76850 on Biotech Values

Replies to #76850 on Biotech Values

DewDiligence

04/28/09 9:35 PM

#76860 RE: steveporsche #76850

Re: IMCL as a valuation comparator

...BMY was partnered with IMCL back in 2001 so profits are split with them.

The US economics of this partnership are highly favorable to LLY (IMCL), as explained in my reply to p3analyze (#msg-37386017). So much so that, from a valuation standpoint, Erbitux is tantamount to a wholly owned LLY drug in the US market.